Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
Dow
Colorcon
Johnson and Johnson
Mallinckrodt

Last Updated: July 5, 2020

DrugPatentWatch Database Preview

ERYTHROMYCIN Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Erythromycin, and what generic alternatives are available?

Erythromycin is a drug marketed by Arbor Pharms Llc, Barr, Fougera Pharms, Perrigo Co, Teligent Pharma Inc, Elkins Sinn, Akorn, Bausch And Lomb, Perrigo Co Tennessee, Pharmaderm, Pharmafair, Paddock Llc, Alpharma Us Pharms, Lilly, Perrigo New York, Renaissance Pharma, Wockhardt Bio Ag, Mylan, Amneal Pharms Co, Lyne, Tolmar, Ivax Sub Teva Pharms, Watson Labs, Acp Nimble, Life Labs, Amneal Pharms, Ani Pharms Inc, Par Pharm Inc, Dista, Naska, Parke Davis, Abraxis Pharm, Baxter Hlthcare, Teva Parenteral, Lederle, and Purepac Pharm. and is included in sixty-five NDAs.

The generic ingredient in ERYTHROMYCIN is erythromycin stearate. There are one hundred and three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the erythromycin stearate profile page.

Drug patent expirations by year for ERYTHROMYCIN
Drug Prices for ERYTHROMYCIN

See drug prices for ERYTHROMYCIN

Drug Sales Revenue Trends for ERYTHROMYCIN

See drug sales revenues for ERYTHROMYCIN

Recent Clinical Trials for ERYTHROMYCIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Yonsei UniversityN/A
Prof Dr Jan TackN/A
Beijing Children's HospitalN/A

See all ERYTHROMYCIN clinical trials

Pharmacology for ERYTHROMYCIN
Medical Subject Heading (MeSH) Categories for ERYTHROMYCIN

US Patents and Regulatory Information for ERYTHROMYCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare ERYTHROMYCIN LACTOBIONATE erythromycin lactobionate INJECTABLE;INJECTION 062993-002 May 9, 1989 DISCN No No   Start Trial   Start Trial   Start Trial
Barr ERYTHROMYCIN ESTOLATE erythromycin estolate CAPSULE;ORAL 062162-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Amneal Pharms Co ERYTHROMYCIN erythromycin TABLET, DELAYED RELEASE;ORAL 210954-001 Jul 2, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Watson Labs ERYTHROMYCIN STEARATE erythromycin stearate TABLET;ORAL 062121-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Life Labs ERYTHROMYCIN ESTOLATE erythromycin estolate SUSPENSION;ORAL 062362-001 Dec 17, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
Dow
Colorcon
Johnson and Johnson
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.